
Jan 12 (Reuters) - Moderna Inc MRNA.O:
MODERNA: REITERATES PLAN TO DELIVER UP TO 10% REVENUE GROWTH & GAAP OPERATING EXPENSE REDUCTIONS IN 2026
MODERNA: CASH, CASH EQUIVALENTS & INVESTMENTS AT YEAR-END 2025 ABOUT $8.1 BILLION
MODERNA: POTENTIAL FIRST APPROVALS OF FLU AND FLU/COVID COMBINATION PRODUCTS IN 2026
MODERNA: EXPECTS GAAP OPERATING EXPENSES OF $4.2 – $4.6 BILLION IN 2027, TARGETING CASH BREAKEVEN IN 2028
MODERNA: IMPROVING 2025 EXPECTED GAAP OPERATING EXPENSES BY $200 MILLION TO $5.0 – $5.2 BILLION
MODERNA OUTLOOK 2025 REVENUE ABOUT $1.9 BILLION VERSUS IBES ESTIMATE $1.89 BILLION
Source text: [ID:]